COMMUNIQUÉS West-GlobeNewswire

Lumin Health Appoints Matthew Mosquera, MD, MS, as Regional Medical Director and Site Director of Lumin Cambridge
07/04/2026
BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Lumin Health, a physician-led provider of interventional behavioral health care offering SPRAVATO® (esketamine) nasal spray and ketamine-based therapies in a purpose-built [...]
SRx Health Solutions Returns +5.69% in March 2026 Driven by EMJX Artificial Intelligence (AI) Engine
07/04/2026
+5.69% return for shareholders compares to -4.98% decline on the S&P 500 index SRx Health Board of Directors to consider implementing a quarterly dividend policy based on percentage of profits from portfolio NORTH [...]
PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications
07/04/2026
BOSTON and COLUMBIA, Md., April 07, 2026 (GLOBE NEWSWIRE) -- PathAI, a leading provider of AI-powered pathology solutions, and MedStar Health, a leading health system headquartered in Columbia, Maryland, today announced [...]
HeartFocus and Inteleos Launch First AI Cardiac POCUS Certification
07/04/2026
Rigorous training and certification gives clinicians a validated pathway to AI-enabled cardiac POCUS proficiency ROCKVILLE, Md. and BORDEAUX, France, April 07, 2026 (GLOBE NEWSWIRE) -- HeartFocus , the AI-enabled [...]
Inc. Recognizes U.S. Oral Surgery Management for Growth
07/04/2026
USOSM Ranked 90 on 2026 List of Fastest Growing Companies in the Southwest IRVING, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- Inc., the leading media brand and playbook for the entrepreneurs and business leaders shaping [...]
NexTel Medical Corp Announces Pivotal Milestone in Commercial Launch of Patent-Protected NANOG DNA Cancer Screening Test
07/04/2026
ORLANDO, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- NexTel Medical Corp f/k/a Exousia Pro, Inc. ( OTCPK: MAJI ), a clinical-stage biotechnology leader specializing in proprietary exosome-based delivery systems, is proud [...]
Cognition Therapeutics to Present at Needham Virtual Healthcare Conference
07/04/2026
PURCHASE, N.Y., April 07, 2026 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (Nasdaq: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, announced that the Company’s president [...]
CRISPR Therapeutics to Present at the 25th Annual Needham Virtual Healthcare Conference
07/04/2026
ZUG, Switzerland and BOSTON, April 07, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today announced that members of its senior management team will present at the 25th Annual Needham Virtual Healthcare [...]
Inhibikase Therapeutics Announces Enrollment of First Patient in IMPROVE-PAH Global Phase 3 Study of IKT-001 in the Treatment of Pulmonary Arterial Hypertension
07/04/2026
WILMINGTON, Del., April 07, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial [...]
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01
07/04/2026
Trial extension completed as planned with three-year clinical efficacy data expected to be presented in the second half of 2026 The trial has already yielded encouraging one- and two-year data including a 75% Objective [...]
Corbus Pharmaceuticals Announces Broad Alignment with FDA on Registration Path for CRB-701 in Second-Line HNSCC and Cervical Cancer
07/04/2026
FDA feedback enables Corbus to proceed with proposed registrational study design and endpoints to support potential accelerated approval in second-line HNSCC and cervical cancer Updated CRB-701 monotherapy data accepted [...]
electroCore Announces First Patient Enrollment in Investigator-Led Study of gammaCore™ nVNS for PTSD
07/04/2026
ROCKAWAY, N.J., April 07, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the enrollment of the first eight patients in a [...]
Palvella Therapeutics Appoints Accomplished Commercial Leader Kent Taylor as Senior Vice President of Sales
07/04/2026
Mr. Taylor brings a strong track record launching multiple high-profile therapies, most recently serving as Senior Vice President, Sales at Arcutis Biotherapeutics (Nasdaq: ARQT), where he led U.S. sales efforts for [...]
Route 92 Medical Announces $50 Million Growth Financing
07/04/2026
New investor Sectoral Asset Management joins growth financing round to support acceleration of commercial growth WEST JORDAN, Utah, April 07, 2026 (GLOBE NEWSWIRE) -- Route 92 Medical, Inc., a privately held medical [...]
CervoMed to Provide Neflamapimod Clinical Program Update and Participate in a Panel on Biomarkers at 2026 Lewy Body Dementia Association Annual Meeting
07/04/2026
Update will include new MRI analyses from the Phase 2b RewinD-LB clinical trial, status of global regulatory discussions, and finalized Phase 3 trial design Additional data from MRI analyses will also be featured at [...]
Lyell Immunopharma Announces Participation in 25th Annual Needham Virtual Healthcare Conference
07/04/2026
SOUTH SAN FRANCISCO, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Lyell Immunopharma, Inc. (Nasdaq: LYEL), a late-stage clinical company advancing a pipeline of next-generation chimeric antigen receptor (CAR) T-cell [...]
NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer
07/04/2026
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SIM0505 for the treatment of women with platinum resistant ovarian cancer (PROC) Phase 1 data for SIM0505 to be presented at ASCO 2026; [...]
Calidi Biotherapeutics Announces Speaker Presentation at ASGCT Conference in Boston on May 14, 2026 Highlighting the RedTail Platform’s Ability to Deliver Genetic Medicines to Distal Sites of Disease with Systemic Therapy
07/04/2026
SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, will [...]
Plus Therapeutics Receives AMA PLA Code for CNSide® CSF Tumor Cell Enumeration Test, Advancing Reimbursement and U.S. Commercial Adoption
07/04/2026
New dedicated billing code facilitates payer reimbursement, supports clinician adoptions, and enables national utilization tracking HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (“ [...]

Pages